Brief: Nicox's Completes Enrollment Of NCX 4251 Phase 2B Blepharitis Trial
01/06/2021 08:22
June 1 (Reuters) - Nicox SA NCOX.PA :
* REG-NICOX’S COMPLETES PRE-DEFINED ENROLLMENT OF NCX 4251
MISSISSIPPI PHASE 2B BLEPHARITIS TRIAL
* OVER 200 PATIENTS RANDOMIZED
* TOP-LINE RESULTS EXPECTED IN SEPTEMBER 2021
Source text for Eikon: ID:nGNE1l7KDj
Further company coverage: NCOX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))